JPH0547222B2 - - Google Patents
Info
- Publication number
- JPH0547222B2 JPH0547222B2 JP84202133A JP20213384A JPH0547222B2 JP H0547222 B2 JPH0547222 B2 JP H0547222B2 JP 84202133 A JP84202133 A JP 84202133A JP 20213384 A JP20213384 A JP 20213384A JP H0547222 B2 JPH0547222 B2 JP H0547222B2
- Authority
- JP
- Japan
- Prior art keywords
- tube
- chamber
- cells
- blood
- irradiation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000007788 liquid Substances 0.000 claims description 9
- 238000004891 communication Methods 0.000 claims description 3
- 230000001678 irradiating effect Effects 0.000 claims description 3
- 239000012298 atmosphere Substances 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 238000001228 spectrum Methods 0.000 claims description 2
- 238000005286 illumination Methods 0.000 claims 4
- 210000004027 cell Anatomy 0.000 description 31
- 210000004369 blood Anatomy 0.000 description 21
- 239000008280 blood Substances 0.000 description 21
- 238000000034 method Methods 0.000 description 17
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 10
- 230000005855 radiation Effects 0.000 description 9
- 125000006850 spacer group Chemical group 0.000 description 7
- 239000000463 material Substances 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000000265 leukocyte Anatomy 0.000 description 5
- 210000004698 lymphocyte Anatomy 0.000 description 5
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 239000000835 fiber Substances 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- BUNGCZLFHHXKBX-UHFFFAOYSA-N 8-methoxypsoralen Natural products C1=CC(=O)OC2=C1C=C1CCOC1=C2OC BUNGCZLFHHXKBX-UHFFFAOYSA-N 0.000 description 2
- 239000004593 Epoxy Substances 0.000 description 2
- QXKHYNVANLEOEG-UHFFFAOYSA-N Methoxsalen Chemical compound C1=CC(=O)OC2=C1C=C1C=COC1=C2OC QXKHYNVANLEOEG-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 230000001268 conjugating effect Effects 0.000 description 2
- 230000021615 conjugation Effects 0.000 description 2
- 238000006880 cross-coupling reaction Methods 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000007599 discharging Methods 0.000 description 2
- 210000003743 erythrocyte Anatomy 0.000 description 2
- 229960004469 methoxsalen Drugs 0.000 description 2
- SQBBOVROCFXYBN-UHFFFAOYSA-N methoxypsoralen Natural products C1=C2OC(=O)C(OC)=CC2=CC2=C1OC=C2 SQBBOVROCFXYBN-UHFFFAOYSA-N 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 238000003466 welding Methods 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 229920002284 Cellulose triacetate Polymers 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 1
- NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 238000003339 best practice Methods 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- 239000007767 bonding agent Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- HGAZMNJKRQFZKS-UHFFFAOYSA-N chloroethene;ethenyl acetate Chemical compound ClC=C.CC(=O)OC=C HGAZMNJKRQFZKS-UHFFFAOYSA-N 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 229920006332 epoxy adhesive Polymers 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 238000012261 overproduction Methods 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 210000001082 somatic cell Anatomy 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000026676 system process Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000003104 tissue culture media Substances 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3622—Extra-corporeal blood circuits with a cassette forming partially or totally the blood circuit
- A61M1/36226—Constructional details of cassettes, e.g. specific details on material or shape
- A61M1/362262—Details of incorporated reservoirs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3681—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation
- A61M1/3683—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by irradiation using photoactive agents
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- External Artificial Organs (AREA)
- Radiation-Therapy Devices (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Description
æ¬çºæã¯ã现èãç
§å°ããåéã«é¢ãããã®ã§
ããããã詳现ã«ã¯ãè¡çã®U.V.å ã«ããäœå€
åŠçã«é¢ãããã®ã§ããã 人ã®å€ãã®ç çç¶æ ãããªã³ãçãå«ãããçš®
ã®çœè¡çã®éå°ç£çã«ãã€ãŠç¹åŸŽã¥ããããïŒäž
è¬ã«ã¯å šè¡ãå«ããã®ä»ã®çްèéå£ã«æ¯ã¹ãŠïŒã
ãšã¯ããç¥ãããŠãããéå°ã®ãªã³ãçéå£ã¯ã
æ£è ã«å¯ŸããŠåšå®ã®æ©èœçæå·ãå«ãå€ãã®æªåœ±
é¿ãäžããæ»ããã³ãããããšãããã ãšãã«ãœã³ïŒEdelsonïŒã®ç±³åœç¹èš±ç¬¬4321919
å·ã¯ãå šè¡ãåŠçãããã®ãããªéå£ãæžããæ¹
æ³ãèšèŒããŠãããäžè¬çã«ã¯ãã®æ¹æ³ã¯ãçŽ
320ã400nïœé åã®U.V.A.ïŒé·æ³¢é·çŽ«å€ç·ïŒã®å
åšäžã§DNAãšå âä»å ç©ã圢æããããšã®ã§ã
ãçš®é¡ã®æº¶è§£ããœã©ã¬ã³ã§å šè¡ãåŠçããããšã
ãæããããœã©ã¬ã³ãšãªã³ãçæ žé žãšã®éã«çæ
ããå ±æçµåã¯ãããããŠåŠçãããªã³ãçã®ä»£
è¬é»å®³ããããããããã®çްèã¯ãã®åŸæ£è ã«æ»
ãããã ãã®ã·ã¹ãã ã¯ãçåœããã³ãããç¶æ ã«ãã
æ£è ã«ãã€ãŠå€§ããªæããšãªããšã¯ãããå€ãã®
å®éçåé¡ããŸã æ®ã€ãŠãããç¹ã«ããšãã«ãœã³
ã¯çµæžçæ¹æ³ã§çްèãç §å°ããé©åœãªè£ 眮ãçšæ
ããããšãã§ããªãã€ãã ããã§ãæ¬çºæã¯ããšãã«ãœã³ã®æ¹æ³ãå®çŸã
ããããå®çšçãªè£ 眮ããã³ãã®äœ¿ç𿹿³ãæäŸ
ããããšãç®çãšãããããªãã¡ãæ¬çºæã¯ãäœ
å€ã«æ¡åããã现èã«ã€ããŠæŸå°ç·ãšå ±åœ¹ããã
ïŒæŸå°ç·ãä»ããŠãªã³ãçã®æ žé žãšããœã©ã¬ã³ç
ã®å 掻æ§ç©è³ªãçµåãããããšïŒãšãã«ãœã³ã®æ¹
æ³ããå®éšå®€ã¬ãã«ã§ã¯ãªãã忥ããŒã¹ãå žå
çã«ã¯ç é¢ã§å®æœããããšã®ã§ããè£ çœ®ããã³ã
ã®äœ¿ç𿹿³ãæäŸãããã€ãŸããé»ç£æ³¢ïŒçŽ«å€
ç·ïŒã®ç §å°å æºã¯å®éšå®€ã§ã¯è€éãªãã®ã§ã容æ
ã«æºåããããšãã§ãããã€ãã®äœ¿çšãçç·Žè ã
è¡ãããšãã§ããããç é¢ã§ã¯ããæ®éã®ïŒé»ç£
æ³¢ã®ç §å°ã«ã€ããŠã¯çç·ŽããŠããªãïŒè·å¡ã倿°
ã®æ£è ã«å¯Ÿããäºãå®ããããæ¹æ³ïŒãããã³ãŒ
ã«ïŒã«æ²¿ã€ãŠç¹°ãè¿ãè¡ãå Žåãã»ãšãã©ã§ã
ããããã§ããã®ãããªéçç·Žè ã«ã容æã«æºå
ã§ããè£ çœ®ããã³ãã®äœ¿ç𿹿³ãæäŸããããšã
ããã®ã§ããã åŸæ¥ã®æè¡ã¯ã现èã®ç §å°ã«åœãã€ãŠããã©ã¹
ã³ãã«ã©ã ãåå è¢å å 床èšçšããŠãããããã
ãªç¿çã®å®¹åšãå©çšããŠãããããªãã¡ãæŸå°ç·
ã«æŽé²ãã现èã¯ãããã®å®¹åšã«å容ãã现èã
å容ãã容åšã¯ãç §å°å æºã«é£æ¥ããŠé 眮ãã
ãããããããã®ãããªçްèç §å°ã·ã¹ãã ã¯ãå ±
åœ¹ã«æå¹ãªæ³¢é·ãæããæŸå°ç·ãã现èãå容ã
ã容åšã®èªå·±é®èœå¹æãåžåã®ããã«ã容åšå ã®
现èãã¹ãŠã«ã¯ç §å°ãããªããšããæ¬ ç¹ãããã
ãŸããã®ã·ã¹ãã ã¯ã现èã容åšå ã«å容ããã
ãããåäœã§åŠçãããããåŠçéã«å¶éããã
ããããã¯èšåºã®èгç¹ããã¯å€§ããªçæãšãªãã ããã§ãæ¬çºæã¯ãŸãããã®ãããªãããåäœ
ã®åŠçã·ã¹ãã ã«ããããæŸå°ç·ãç §å°ãã¹ã现
èãé£ç¶çã«æµéã»åŠçã§ããè£ çœ®ããã³ãã®äœ¿
çšæ¹æ³ãæäŸããããšãç®çãšããã ããã«ãåŸæ¥ã¯ç §å°ãã¹ã詊æããç §å°å æºã
ãã®æŸå°ç·ãå åŠçã«ãªã¬ãŒããè€æ°ã®ç¹ç¶ã®åš
å²ã«æµéãããè£ çœ®ããã€ãããããããã®ãã
ãªè£ 眮ãæå¹ãªåãããã«ã¯ãç¹ç¶ãå åŠçã«ã¯
ããŸãæ©èœãããæŸå°ç·ãç¹ç¶å£ãééããéã«
æ¶å€±ããªãã现èãç §å°ããããšãèŠæ±ãããã
ãããããšããã®ãããªè£ 眮ã¯ãéåžžã®ç §å°æºã§
ã¯æŸå°ç·ã®å ±åœ¹ãååã«éæãããªããããéåžž
ã«å€§åã§é«äŸ¡ãªç §å°æºãå¿ èŠã«ãªãã ãã€ãŠãæ¬çºæã¯ããã®ãããªé«äŸ¡ãªç §å°ç §å°
å æºãå¿ èŠãšããããã®ãããªç §å°å æºã«æ¯ã¹ã
ã°ã¯ããã«å¹ççãªç §å°å æºãå©çšããè£ çœ®ãã
ã³ãã®äœ¿ç𿹿³ãæäŸããããšãç®çãšããã æ¬çºæã®ç®çã«åŸã€ãŠããããããã©ãã¯ã©ã€
ãè¢å ã©ã³ãã®ãããªåžè²©ã®å æºããäŸçµŠããã
å ç·ãå ±åœ¹ãããããã®è£ 眮ãæäŸããããäžå®
æœäŸã«ãããŠãå žåçã«ã¯ç®¡åœ¢ã®ãè¢å ãã©ãã¯
ã©ã€ãã©ã³ããããã倧ããçŽåŸããã€ãšããŠãŒ
ãã«å軞çã«ãšãã€ããããåèšå€åŽããŠãŒãã®
端ã¯å 端ã«ããå°ãããããå€åŽããŠãŒãã«ã¯ã
ç §å°ãã¹ã现èãåãåãå ¥å£ãšãç §å°ããã现
èãæŸåºããåºå£ãããã奜ãŸãã宿œäŸã«ãã
ãŠããã¯ãçŽåŸã®ãã倧ãã第äºã®å€åŽããŠãŒã
ããåè¿°ã®è£ 眮ã«å軞çã«ãšãã€ãããããã®ç«¯
ãå¯å°ç¶æ ã§ç¬¬äžã®å€åŽããŠãŒããšé£çµ¡ããã第
äºã®ããŠãŒããå ¥å£ãšåºå£ãå«ã¿ããããã¯ãã
ããç §å°ãã¹ã现èãåãåããç §å°ãã¿ã®çްè
ãæŸåºããã第äºã®å®æœäŸã«ãããŠãå æºãšå¯å°
ç¶æ ã§é 眮ãããå åŽããŠãŒãã«ãã€ãŠåœ¢æãã
ã宀ã¯ãå·åŽå®€ãšããŠåœ¹ç«ã¡ããã«ãã®ç±å¹æã
æžããã æã奜ãŸãã宿œäŸã«ãããŠã倿°ã®åè¿°ã®ã
ãŠãŒããé åããŠã奜ãŸããã¯äœ¿ãæšãŠå¯èœã®ã«
ã»ããã圢æãããæµãã¯åè¿°ã®ããŠãŒãé åã®
åã ãéã€ãŠé£ç¶çã«ããããäžçš®ã®ãµãŒãã³ã
ã³æ§é æ§ã«è¡ãããã®ã奜ãŸãããããã«ãã€ãŠ
åããŠãŒãè£ çœ®ã¯å¥œãŸããã¯åçŽã«ä¿æãããå
匷ãè¡æµããããåçŽã«ééãããã®ããç©ºæ°æ³¡
çã¯å¹æçã«æµãåºãããããã®å®æœäŸã¯ã«ã»ã
ãã®äžç«¯ã«è¡æ¶²ã®å ¥å£ãšåºå£ãåããããã詳现
ã«ã¯ããã®å®æœäŸã«ãããŠå ¥å£ã¯ç¬¬äžã®ããŠãŒã
åè£ çœ®ã®æãåºã®éšåã«å ·åãããã®ãçæ³çã§
ãããããããŠè¡æ¶²ã®åºå£ã¯ãäžçªæåŸã®åæ±ç¶
ç §å°è£ 眮ã®ãŠã€ãºããšã€ãªããã®ã奜éœåã§ã
ãã ãã®ããã«ããŠãåèšã®è£ 眮ã§ç §å°åŠçãã¹ã
äœçްèãäœãããšãåºããç §å°å æºããšãå·»ã宀
ãééãããããããäœå ã«æ»ãããã®ãããªåŠ
çã¯ãå æºããã®ç §å°ã§æŽ»æ§åããããããœã©ã¬
ã³çŸ€äžã«ãããããªååç©ãšç §å°ããã¹ã现èãš
ãæ¥è§Šãããããšãå«ãã§ããããããã§çšãã
ãæŽ»æ§åãããããšããçšèªã¯ããã®ååç©ãç §
å°åã¯ã»ãšãã©äœã®åœ±é¿ããããããã®åŸã®ç §å°
ããåºå¥å¯èœäžã€æ€åºå¯èœã®æ¹æ³ã§åŠç现èã«åœ±
é¿ãäžããããšãæå³ããããã®ãããªåºå¥å¯èœ
ã§æ€åºå¯èœã®æ¹æ³ãšã¯ãäŸãã°ã现èèçµ±åæ§ã®
ç Žå£ã现èå ã®DNAã®å€åçãããããŠåŠçã
ã现èã®æå¹æ§åã¯ç掻åã®æ¬è³ªçåªå€±ãããã
ãããªãã®ãå«ãã ããœã©ã¬ã³çŸ€ã§ã¯å€æ°ã®U.V.掻æ§åååç©ã
ç¥ãããŠããããïŒâã¡ããã·ããœã©ã¬ã³ãæã
ããããååç©ã§ããããã®ååç©ãããã³äžè¬
ã«ã¯å€ãã®ããœã©ã¬ã³ã«ãšã€ãŠæå¹ãªç §å°ã¯ãçŽ
320ã400nïœç¯å²ã®çŽ«å€ç·ã¹ãã¯ãã«ã§ãããã
ã®ãããªã¹ãã¯ãã«ïŒU.V.AïŒãäžããå æºã¯ã
ã·ã«ããã¢F8TSïŒBLB 8Wãã©ãã¯ã©ã€ãT5
ãã«ãŒãã«ãã§ãããã»ãšãã©åããã®ãããžãš
ãã©ã«ãšã¬ã¯ããªãã¯ç€ŸïŒGeneral ElectricïŒã®
ãããªä»ã®è£œé äŒç€Ÿãããå ¥æã§ããããããã®
ãã«ãã¯ãäŒçµ±çã«ãé©åœãªé»æ°çãœã±ãããã
ã³é»åäŸçµŠã容æã«è¡ããå°ããâè¢å âå管é
åã«ããã 第ïŒå³ãåç §ãããšããã®ãããªå æºïŒïŒãå
軞çã«è£ æ¶ãããããŠãŒãïŒïŒããã³ïŒïŒãšå ±ã«
瀺ããããæŽã«ç¬¬ïŒå³ãåç §ãããšãå åŽããŠãŒ
ãïŒïŒã¯ã奜ãŸããã¯ã¹ããŒãµãªã³ã°ïŒïŒãäžç«¯
ã«å ·åããå æºïŒïŒãšå軞ã®é 眮ãç¶æããããš
ããã·æ¥çå€ã®ãããªé©åœãªå¯å°âåã¯æ¥åå€ã
åã¯çš®ã ã®ãã©ã¹ããã¯ã¹ããæº¶æ¥ãããã®ã«ç¹
ã«æçšãªå¡©åã¡ãã¬ã³ã®ãããªæº¶å€ãçšããããš
ã«ãã€ãŠæ°žä¹ çå¯å°é£çµãå¯èœã§ãããå åŽããŠ
ãŒãã«ã¯ãªãªãã€ã¹ïŒïŒããšãã€ãããã宀ã®é
ã€ãŠå¯Ÿåæµãèªç±ã«æµããããã«ãã€ãŠå æºïŒïŒ
ãå·ãããè£ çœ®ãäœåããåšå²ã®æ¡ä»¶ã«ãã€ãŠ
ã¯ã匷å¶ç©ºæ°çã®ãããªé©åœãªææ®µã«ãã€ãŠå®€ã
éãç©ºæ°æµãå¢å ããããšãæãŸããããç¥ããª
ãã æã奜ãŸãã宿œäŸã«ãããŠãå åŽããŠãŒãïŒ
ïŒã¯ãã¢ã¯ãªã«ãããªã¢ã»ãã«ã»ã«ããŒã¹ãåã¯
é©åœãªç¡¬è³ªPVCã®ãããªå®è³ªçã«U.V.ãééã
ãææããäœããããã³ã¹ãããã³å©çšæ§äžŠã³ã«
U.V.ééæ§ã®é¢ããã¿ãŠã¢ã¯ãªã«ãæã奜ãŸã
ãææã§ãããåŸã€ãŠæåã®å®æœäŸã«ãããŠçæ³
çã«äœ¿çšãããã æŽã«ç¬¬ïŒããã³ïŒå³ãåç §ããŠãå€åŽããŠãŒã
ïŒïŒãå åŽããŠãŒãïŒïŒã«ã奜ãŸããã¯ã¹ããŒãµ
ïŒïŒã«ãã€ãŠå軞çã«ãšãã€ãããããã¹ããŒãµ
ïŒïŒãçšãããšãã€ãã¯ãå žåçã«ã¯å€åŽããŠãŒ
ãïŒïŒãã¹ããŒãµïŒïŒããã³å åŽããŠãŒãïŒïŒã
äžç·ã«ååŠçã«ã溶æ¥ãããã®ã«é©ããæº¶åªã䜿
çšããããšã«ãã€ãŠå¯å°ç¶æ ã«è¡ããããå€åŽã
ãŠãŒãïŒïŒäžã«ã¯ç §å°ããã¹ãæ¶²äœè©Šæãããã
ãåãåã€ããæŸåºãããããå ¥å£ããã³åºå£ïŒ
ïŒããšãã€ããããã奜ãŸãã宿œäŸã«ãããŠã¯
ãããã®å£ïŒïŒã¯ãªã¢ãŒåã³ãã¯ã¿ãŒã§ããã ã¹ããŒãµïŒïŒã¯çªãåºãâæâç¶ã®çªèµ·ããã€
ã®ãèªãããããããã¯å ¥å£ïŒïŒããã³åºå£ïŒïŒ
ã®å察åŽã®å£ã«äœçœ®ããã®ã奜ãŸããããã®ãã
ãªçªèµ·ã¯ãæµããªãâãã®å Žæã«èç©ããããšã«
ãªã€ãããç¥ããªãâæµéãéœåè¯ãæžãããã
ã®ãããªçªèµ·ã¯å®éã«ã¯ãããªã圢ããšã€ãŠãã
ãããšã¯æããã§ãããææãªãã°ãã¹ãŠãåé€
ããŠãããã 第ïŒå³ãæ¬çºæã®åå¥ã®å®æœäŸãæãããã®ã§
ãããããã§ã¯åäžã®å®€ããã«ãïŒïŒãšå軞æ¹å
ã®ããŠãŒãïŒïŒã«ãã€ãŠåœ¢æããããã®æ«ç«¯ïŒïŒ
ã¯ãšããã·ã®ãããªé©åœãªææã§å°ãããããã
ã®å Žåãå æºïŒïŒã®ã¬ã©ã¹ããã³ææïŒïŒã«å¯ç
çã«æ¥çããããšãã§ããç §å°ããã¹ã现èãå«
ã詊æãšã»ãšãã©çžäºäœçšããªãææãé©ããŠã
ããšããããããŠãŒãïŒïŒã«ã¯ãæ¶²äœææãåã
åã€ããæŸåºãããããå ¥å£ããã³åºå£ïŒïŒãå
ãã€ããããã宀å ã®æµãã®æ¹åã¯éèŠã§ãªãã
ã©ã¡ãã®æ¹åã«æµããŠããããããã第ïŒå³åã¯
第ïŒå³ã«ç€ºãåã®ã©ã¡ããã倿°çšãããããªå Ž
åã«ã¯ã第ïŒå³ã«ç€ºãããã«åçŽã«äžŠã¹ãããšã
奜ãŸãããæµãã¯åºããé éšãžé²ãããã«èšèšã
ãããïŒæ¬ã®è£ 眮ã䜿ãå Žåã§ãã€ãŠããããã¯
空æ°ã®æ³¡ãé€å»ããããã«å¥œãŸããæµãã®é 眮ã§
ãã€ãŠããããã®æ³¡ã¯ãé€å»ãããªãå¥ã®é 眮ã§
ã¯æç²ãããŠããŸãã 第ïŒå³ã¯ã«ã»ãããšããŠããã«åŒçšããæã奜
ãŸãã宿œäŸã§ãããã«ã»ããã¯è€æ°ã®ç §å°å®€ïŒ
ïŒããã¡ããã®åã ã¯ç¬¬ïŒå³ã«ç€ºãã宿œäŸãšã
æ§é äžã¯ã»ãåãã§ãããçæ³çãªé 眮ã¯ãã®ã
ããªç §å°å®€ïŒïŒãïŒåãã€ããå®éçæ§é çå¶çŽ
ããã³äœ¿ãæããèæ ®ããŠããã®ãããªå®€ããã
ããå€ããåã¯ããããå°ã䜿ã€ãŠããããç §å°
ç®¡ã®æ°ããµããè¡æ¶²ããã®åã ã®ç®¡ã匷å¶çã«æµ
ãããã«ãªããšããããæµããæ¶²ã«åœããç §å°é
ãå¢å ããããšã¯å®¹æã«çè§£ãããã 第ïŒå³ã«ç€ºãã«ã»ããã§ãè¡æ¶²ã¯å ¥å£ïŒïŒãé
ããŠç §å°å®€ïŒïŒã«é£çµ¡ãããå ¥å£ïŒïŒã¯ã«ã¢ãŒã
ãã¯ã§ããããæº¶åªæº¶æ¥ã®ãããªäœããã®é©åœãª
ææ®µã«ãã€ãŠããŠãŒãã³ã°ã»ãããä»çããŠãã
端ãªãå ¥å£ãã€ãã§ãããã©ã¡ããã§ãããç §å°
ããã¹ãæ¶²ã¯ããããäžè¬ã«ã¯äžæ¹ãžæµãããã
ããåºå£ïŒïŒã次ã®ç §å°å®€ã®å ¥å£ïŒïŒã«ã€ãªãã
ãã¬ãã·ãã«åã¯ãã¬ãã·ãã«ã§ãªãããŠãŒãç³»
ããæã亀åçµåææ®µïŒïŒã«ãã€ãŠäžæ¹ãžæµã
ãããã®ããã»ã¹ã¯ãç¢å°ã®æ¹åã«ãµãŒãã³ãã€
ã³æµïŒsurpentine flowïŒãçæãããããã¯ç©º
æ°æ³¡ã®ãããªãã®ãé€ãã®ã«ããæå¹ã§ããããš
ãããã€ããç §å°å®€ïŒïŒãééããæ¶²æµããæµã
ã®æ¹åã«ãããããã©ã³ãïŒïŒããã®ç §å°ã«ãã€
ãŠçãã圱é¿ãåãããªãã°éæ¹åãçšããŠãã
ãããšã¯æããã§ãããæåŸã«æ¶²ã¯æåŸã®ç §å°å®€
ïŒïŒã®åºå£ïŒïŒã«éããã«ã»ããåºå£ïŒïŒãéã€
ãŠã«ã»ããããæŸåºãããã第ïŒå³ã§ãã®åºå£
ã¯ãåºå£é£çµããŠãŒãïŒïŒãçµãŠãã«ã»ããå ¥å£
ïŒïŒãšåãåŽã«ç€ºãããããã®é åã¯é£çµããã³
æäœã容æã«ããããšããã®ã¯ãã¹ãŠãã®ãããª
é£çµã¯ã«ã»ããã®çæ¹ã®ç«¯ã§è¡ãããããã§ã
ãã奿³ãšããŠãã«ã»ããåºå£ïŒïŒãã«ã»ããå ¥
å£ïŒïŒãšåã圢åŒã§ãçŽæ¥ãæåŸã®åºå£ïŒïŒã«ã
ã€ãŠããããåç §å°å®€ïŒïŒãç §å°å®€å ã«äœçœ®ãã
ç §å°ã©ã³ãïŒïŒãæ¯ããã¿ãïŒïŒããã€ãã¿ãå·»
ã®éå£ã¯å å£ïŒïŒãšçµã¿åã€ãŠã©ã³ãïŒïŒãåã
å·»ã空æ°ã¹ããŒã¹ã圢æããããããã¯å€§æ°ãšèª
ç±ã«é£çµ¡ããŠã第ïŒå³ã®ããŠãŒãïŒïŒã«ãã€ãŠåœ¢
æãããå éšå·åŽå®€ãšåæ§ã®æ¹æ³ã§å·åŽããã 第ïŒå³ã«ã¯åã ã«äº€åããé£çµããŠãŒãææ®µïŒ
ïŒã瀺ãããŠãããšã¯ãããé©åœãªæåããã»ã¹
ãçšããŠãã®ãããªææ®µãã«ã»ããèªèº«ã®åºæã®
éšåã«ãªãããã«ããŠãããããšã¯åœç¶ã§ããã
ãã®ãããªé åã¯ãé£çµéšãå°ãããŠãäžéœåãª
æŒãã®ãããæ©äŒãæžãããªããã°ãªããªããšã
ã芳ç¹ããã¯å¥œéœåã§ããããã³ãïŒïŒããããŠ
ãŒãã»ããïŒå³ç€ºãããŠããªãïŒãçµç±ãããã
ãªã³åã¯ãã®ä»ã®ååºé»æ¢æº¶æ¶²ã®æµããããã³é
å¿åé¢åšïŒïŒãããã³ãïŒïŒãéãè¡æ¶²ã®æµã
ã¯ãã³ã³ãããŒã«ããã«ïŒïŒã«ãã€ãŠé çªã«ã³ã³
ãããŒã«ãããã¯ã©ã³ãïŒïŒïŒ¡ïŒïŒ¢ããã³ïŒ£ã«ã
ã€ãŠã³ã³ãããŒã«ããããé å¿åé¢åšïŒïŒã¯ãæ
äœè ãããŒãïŒïŒããèŠãŠãå šè¡ã®å¯çœè¡çéšå
ãçæããæã決å®ãããé£ç¶ãããŒã¿ã€ãã§ã
ãããã¹ãŠã®æº¶æ¶²ã¯ãããã«ïŒïŒã«æ¥ããå åŽã«
ã€ãäžãã€ãŠããããã°ïŒå³ç€ºãããŠããªãïŒã«
éãããããåŠçåŸãåŠçè¡æ¶²ãšæªåŠçè¡æ¶²ã¯ã
ãªããã¹ã¿ã³ãïŒïŒã«ã€ãäžããããæ£è ã«æ»ã
ããã å®éšäŸ ïŒ äž¡ç«¯ãâãªã³ã°ãšãšããã·ææãšã®çµã¿åã
ãã§å°ããã第ïŒå³ã«ç€ºããããªè£ 眮ããã·ã«ã
ãã¢F8T5ïŒBLBã©ã³ããšå ±ã«çšãããç°¡åãªå
埪ç°ã·ã¹ãã ããè¡æ¶²ãå ¥ããåçŽã«çœ®ãããè£
眮ã®åºéšãšé£çµ¡ãããã¬ãã·ãã«ããã°ãå«ãã§
æãããã«äœããããè¡æ¶²ã¯ã©ã³ãã®åšå²ãæµ
ãã宀ãäžæ¹ã«æµããåºå£ãªãªãã€ã¹ããåºãŠã
ããã°ã«æ»ããããçµåã¯ãããŒã©ãŒãã¢ãªã³ã°
ã¿ã€ããã³ããéãæãããã¬ãã·ãã«ããŠãŒã
ïŒã¿ã€ãŽã³ããŠãŒãã³ã°ïŒTygon tubingïŒã«ãã€
ãŠè¡ããããå路容éã¯ãïŒã¡ããã·ããœã©ã¬ã³
62nïœïŒmlãå«ãåžéæ°é®®ããè¡æ¶²150mlã§ãã€
ããèµ€è¡çæ¿åºŠã¯6.7Ã106ïŒmlããããŠçœè¡çæ¿
床ã¯1.4Ã106ïŒmlã§ãã€ããè£ çœ®ã®ãã©ã€ãã³ã°
容éã¯25mlã§è¡æ¶²å±€ã®åãã¯0.070ã€ã³ãïŒçŽ
0.178cmïŒãå³ã¡ãã«ããšãåšå²ãžã€ã±ããåã¯ã
ãŠãŒãã®å é¢ãšã®è·é¢ã0.07ã€ã³ãïŒçŽ0.178cmïŒ
ã§ãã€ããè¡æµé床ã¯ïŒåé50mlã«ç¶æãããã
ååŠç詊æããU.V.被æã®åã«æ¡åããããã
ããäžè©Šæããäžã«äžè£ 眮ããã€äžè¿°ã®ãããªå
è·¯ãééããããã®è³æã6.3ãžãŠãŒã«ïŒmlã§ç §
å°ãããå šãåãã·ã¹ãã ã§ãïŒã·ãªãŒãºã«ïŒæ¬
ã®ããŠãŒãã䜿ãããŠããç¹ã ããç°ãªãã·ã¹ã
ã ãäœã€ããåããŠãŒããééããæµãã¯åºéšã
ããŠã€ãºããžãšæµããïŒåéã«190ãžãŠãŒã«ã®ç §
å°ãè¡ããããçœè¡çã¯ïŒæ¥éã¯ç掻åããã€ã
ãšãèªããããããã®ç掻åã¯ãåœæ¥è ã«ã¯åšç¥
ã®æ¹æ³ã§ããããªãã¶ã³ãã«ãŒã®è²çŽ ã«ããåŠç
ãšæ€é¡æ€æ»ã«ããæ±ºå®ããããåŸãããçµæãäž
ã«ïŒè¡šã«ç€ºãã
ããããã詳现ã«ã¯ãè¡çã®U.V.å ã«ããäœå€
åŠçã«é¢ãããã®ã§ããã 人ã®å€ãã®ç çç¶æ ãããªã³ãçãå«ãããçš®
ã®çœè¡çã®éå°ç£çã«ãã€ãŠç¹åŸŽã¥ããããïŒäž
è¬ã«ã¯å šè¡ãå«ããã®ä»ã®çްèéå£ã«æ¯ã¹ãŠïŒã
ãšã¯ããç¥ãããŠãããéå°ã®ãªã³ãçéå£ã¯ã
æ£è ã«å¯ŸããŠåšå®ã®æ©èœçæå·ãå«ãå€ãã®æªåœ±
é¿ãäžããæ»ããã³ãããããšãããã ãšãã«ãœã³ïŒEdelsonïŒã®ç±³åœç¹èš±ç¬¬4321919
å·ã¯ãå šè¡ãåŠçãããã®ãããªéå£ãæžããæ¹
æ³ãèšèŒããŠãããäžè¬çã«ã¯ãã®æ¹æ³ã¯ãçŽ
320ã400nïœé åã®U.V.A.ïŒé·æ³¢é·çŽ«å€ç·ïŒã®å
åšäžã§DNAãšå âä»å ç©ã圢æããããšã®ã§ã
ãçš®é¡ã®æº¶è§£ããœã©ã¬ã³ã§å šè¡ãåŠçããããšã
ãæããããœã©ã¬ã³ãšãªã³ãçæ žé žãšã®éã«çæ
ããå ±æçµåã¯ãããããŠåŠçãããªã³ãçã®ä»£
è¬é»å®³ããããããããã®çްèã¯ãã®åŸæ£è ã«æ»
ãããã ãã®ã·ã¹ãã ã¯ãçåœããã³ãããç¶æ ã«ãã
æ£è ã«ãã€ãŠå€§ããªæããšãªããšã¯ãããå€ãã®
å®éçåé¡ããŸã æ®ã€ãŠãããç¹ã«ããšãã«ãœã³
ã¯çµæžçæ¹æ³ã§çްèãç §å°ããé©åœãªè£ 眮ãçšæ
ããããšãã§ããªãã€ãã ããã§ãæ¬çºæã¯ããšãã«ãœã³ã®æ¹æ³ãå®çŸã
ããããå®çšçãªè£ 眮ããã³ãã®äœ¿ç𿹿³ãæäŸ
ããããšãç®çãšãããããªãã¡ãæ¬çºæã¯ãäœ
å€ã«æ¡åããã现èã«ã€ããŠæŸå°ç·ãšå ±åœ¹ããã
ïŒæŸå°ç·ãä»ããŠãªã³ãçã®æ žé žãšããœã©ã¬ã³ç
ã®å 掻æ§ç©è³ªãçµåãããããšïŒãšãã«ãœã³ã®æ¹
æ³ããå®éšå®€ã¬ãã«ã§ã¯ãªãã忥ããŒã¹ãå žå
çã«ã¯ç é¢ã§å®æœããããšã®ã§ããè£ çœ®ããã³ã
ã®äœ¿ç𿹿³ãæäŸãããã€ãŸããé»ç£æ³¢ïŒçŽ«å€
ç·ïŒã®ç §å°å æºã¯å®éšå®€ã§ã¯è€éãªãã®ã§ã容æ
ã«æºåããããšãã§ãããã€ãã®äœ¿çšãçç·Žè ã
è¡ãããšãã§ããããç é¢ã§ã¯ããæ®éã®ïŒé»ç£
æ³¢ã®ç §å°ã«ã€ããŠã¯çç·ŽããŠããªãïŒè·å¡ã倿°
ã®æ£è ã«å¯Ÿããäºãå®ããããæ¹æ³ïŒãããã³ãŒ
ã«ïŒã«æ²¿ã€ãŠç¹°ãè¿ãè¡ãå Žåãã»ãšãã©ã§ã
ããããã§ããã®ãããªéçç·Žè ã«ã容æã«æºå
ã§ããè£ çœ®ããã³ãã®äœ¿ç𿹿³ãæäŸããããšã
ããã®ã§ããã åŸæ¥ã®æè¡ã¯ã现èã®ç §å°ã«åœãã€ãŠããã©ã¹
ã³ãã«ã©ã ãåå è¢å å 床èšçšããŠãããããã
ãªç¿çã®å®¹åšãå©çšããŠãããããªãã¡ãæŸå°ç·
ã«æŽé²ãã现èã¯ãããã®å®¹åšã«å容ãã现èã
å容ãã容åšã¯ãç §å°å æºã«é£æ¥ããŠé 眮ãã
ãããããããã®ãããªçްèç §å°ã·ã¹ãã ã¯ãå ±
åœ¹ã«æå¹ãªæ³¢é·ãæããæŸå°ç·ãã现èãå容ã
ã容åšã®èªå·±é®èœå¹æãåžåã®ããã«ã容åšå ã®
现èãã¹ãŠã«ã¯ç §å°ãããªããšããæ¬ ç¹ãããã
ãŸããã®ã·ã¹ãã ã¯ã现èã容åšå ã«å容ããã
ãããåäœã§åŠçãããããåŠçéã«å¶éããã
ããããã¯èšåºã®èгç¹ããã¯å€§ããªçæãšãªãã ããã§ãæ¬çºæã¯ãŸãããã®ãããªãããåäœ
ã®åŠçã·ã¹ãã ã«ããããæŸå°ç·ãç §å°ãã¹ã现
èãé£ç¶çã«æµéã»åŠçã§ããè£ çœ®ããã³ãã®äœ¿
çšæ¹æ³ãæäŸããããšãç®çãšããã ããã«ãåŸæ¥ã¯ç §å°ãã¹ã詊æããç §å°å æºã
ãã®æŸå°ç·ãå åŠçã«ãªã¬ãŒããè€æ°ã®ç¹ç¶ã®åš
å²ã«æµéãããè£ çœ®ããã€ãããããããã®ãã
ãªè£ 眮ãæå¹ãªåãããã«ã¯ãç¹ç¶ãå åŠçã«ã¯
ããŸãæ©èœãããæŸå°ç·ãç¹ç¶å£ãééããéã«
æ¶å€±ããªãã现èãç §å°ããããšãèŠæ±ãããã
ãããããšããã®ãããªè£ 眮ã¯ãéåžžã®ç §å°æºã§
ã¯æŸå°ç·ã®å ±åœ¹ãååã«éæãããªããããéåžž
ã«å€§åã§é«äŸ¡ãªç §å°æºãå¿ èŠã«ãªãã ãã€ãŠãæ¬çºæã¯ããã®ãããªé«äŸ¡ãªç §å°ç §å°
å æºãå¿ èŠãšããããã®ãããªç §å°å æºã«æ¯ã¹ã
ã°ã¯ããã«å¹ççãªç §å°å æºãå©çšããè£ çœ®ãã
ã³ãã®äœ¿ç𿹿³ãæäŸããããšãç®çãšããã æ¬çºæã®ç®çã«åŸã€ãŠããããããã©ãã¯ã©ã€
ãè¢å ã©ã³ãã®ãããªåžè²©ã®å æºããäŸçµŠããã
å ç·ãå ±åœ¹ãããããã®è£ 眮ãæäŸããããäžå®
æœäŸã«ãããŠãå žåçã«ã¯ç®¡åœ¢ã®ãè¢å ãã©ãã¯
ã©ã€ãã©ã³ããããã倧ããçŽåŸããã€ãšããŠãŒ
ãã«å軞çã«ãšãã€ããããåèšå€åŽããŠãŒãã®
端ã¯å 端ã«ããå°ãããããå€åŽããŠãŒãã«ã¯ã
ç §å°ãã¹ã现èãåãåãå ¥å£ãšãç §å°ããã现
èãæŸåºããåºå£ãããã奜ãŸãã宿œäŸã«ãã
ãŠããã¯ãçŽåŸã®ãã倧ãã第äºã®å€åŽããŠãŒã
ããåè¿°ã®è£ 眮ã«å軞çã«ãšãã€ãããããã®ç«¯
ãå¯å°ç¶æ ã§ç¬¬äžã®å€åŽããŠãŒããšé£çµ¡ããã第
äºã®ããŠãŒããå ¥å£ãšåºå£ãå«ã¿ããããã¯ãã
ããç §å°ãã¹ã现èãåãåããç §å°ãã¿ã®çްè
ãæŸåºããã第äºã®å®æœäŸã«ãããŠãå æºãšå¯å°
ç¶æ ã§é 眮ãããå åŽããŠãŒãã«ãã€ãŠåœ¢æãã
ã宀ã¯ãå·åŽå®€ãšããŠåœ¹ç«ã¡ããã«ãã®ç±å¹æã
æžããã æã奜ãŸãã宿œäŸã«ãããŠã倿°ã®åè¿°ã®ã
ãŠãŒããé åããŠã奜ãŸããã¯äœ¿ãæšãŠå¯èœã®ã«
ã»ããã圢æãããæµãã¯åè¿°ã®ããŠãŒãé åã®
åã ãéã€ãŠé£ç¶çã«ããããäžçš®ã®ãµãŒãã³ã
ã³æ§é æ§ã«è¡ãããã®ã奜ãŸãããããã«ãã€ãŠ
åããŠãŒãè£ çœ®ã¯å¥œãŸããã¯åçŽã«ä¿æãããå
匷ãè¡æµããããåçŽã«ééãããã®ããç©ºæ°æ³¡
çã¯å¹æçã«æµãåºãããããã®å®æœäŸã¯ã«ã»ã
ãã®äžç«¯ã«è¡æ¶²ã®å ¥å£ãšåºå£ãåããããã詳现
ã«ã¯ããã®å®æœäŸã«ãããŠå ¥å£ã¯ç¬¬äžã®ããŠãŒã
åè£ çœ®ã®æãåºã®éšåã«å ·åãããã®ãçæ³çã§
ãããããããŠè¡æ¶²ã®åºå£ã¯ãäžçªæåŸã®åæ±ç¶
ç §å°è£ 眮ã®ãŠã€ãºããšã€ãªããã®ã奜éœåã§ã
ãã ãã®ããã«ããŠãåèšã®è£ 眮ã§ç §å°åŠçãã¹ã
äœçްèãäœãããšãåºããç §å°å æºããšãå·»ã宀
ãééãããããããäœå ã«æ»ãããã®ãããªåŠ
çã¯ãå æºããã®ç §å°ã§æŽ»æ§åããããããœã©ã¬
ã³çŸ€äžã«ãããããªååç©ãšç §å°ããã¹ã现èãš
ãæ¥è§Šãããããšãå«ãã§ããããããã§çšãã
ãæŽ»æ§åãããããšããçšèªã¯ããã®ååç©ãç §
å°åã¯ã»ãšãã©äœã®åœ±é¿ããããããã®åŸã®ç §å°
ããåºå¥å¯èœäžã€æ€åºå¯èœã®æ¹æ³ã§åŠç现èã«åœ±
é¿ãäžããããšãæå³ããããã®ãããªåºå¥å¯èœ
ã§æ€åºå¯èœã®æ¹æ³ãšã¯ãäŸãã°ã现èèçµ±åæ§ã®
ç Žå£ã现èå ã®DNAã®å€åçãããããŠåŠçã
ã现èã®æå¹æ§åã¯ç掻åã®æ¬è³ªçåªå€±ãããã
ãããªãã®ãå«ãã ããœã©ã¬ã³çŸ€ã§ã¯å€æ°ã®U.V.掻æ§åååç©ã
ç¥ãããŠããããïŒâã¡ããã·ããœã©ã¬ã³ãæã
ããããååç©ã§ããããã®ååç©ãããã³äžè¬
ã«ã¯å€ãã®ããœã©ã¬ã³ã«ãšã€ãŠæå¹ãªç §å°ã¯ãçŽ
320ã400nïœç¯å²ã®çŽ«å€ç·ã¹ãã¯ãã«ã§ãããã
ã®ãããªã¹ãã¯ãã«ïŒU.V.AïŒãäžããå æºã¯ã
ã·ã«ããã¢F8TSïŒBLB 8Wãã©ãã¯ã©ã€ãT5
ãã«ãŒãã«ãã§ãããã»ãšãã©åããã®ãããžãš
ãã©ã«ãšã¬ã¯ããªãã¯ç€ŸïŒGeneral ElectricïŒã®
ãããªä»ã®è£œé äŒç€Ÿãããå ¥æã§ããããããã®
ãã«ãã¯ãäŒçµ±çã«ãé©åœãªé»æ°çãœã±ãããã
ã³é»åäŸçµŠã容æã«è¡ããå°ããâè¢å âå管é
åã«ããã 第ïŒå³ãåç §ãããšããã®ãããªå æºïŒïŒãå
軞çã«è£ æ¶ãããããŠãŒãïŒïŒããã³ïŒïŒãšå ±ã«
瀺ããããæŽã«ç¬¬ïŒå³ãåç §ãããšãå åŽããŠãŒ
ãïŒïŒã¯ã奜ãŸããã¯ã¹ããŒãµãªã³ã°ïŒïŒãäžç«¯
ã«å ·åããå æºïŒïŒãšå軞ã®é 眮ãç¶æããããš
ããã·æ¥çå€ã®ãããªé©åœãªå¯å°âåã¯æ¥åå€ã
åã¯çš®ã ã®ãã©ã¹ããã¯ã¹ããæº¶æ¥ãããã®ã«ç¹
ã«æçšãªå¡©åã¡ãã¬ã³ã®ãããªæº¶å€ãçšããããš
ã«ãã€ãŠæ°žä¹ çå¯å°é£çµãå¯èœã§ãããå åŽããŠ
ãŒãã«ã¯ãªãªãã€ã¹ïŒïŒããšãã€ãããã宀ã®é
ã€ãŠå¯Ÿåæµãèªç±ã«æµããããã«ãã€ãŠå æºïŒïŒ
ãå·ãããè£ çœ®ãäœåããåšå²ã®æ¡ä»¶ã«ãã€ãŠ
ã¯ã匷å¶ç©ºæ°çã®ãããªé©åœãªææ®µã«ãã€ãŠå®€ã
éãç©ºæ°æµãå¢å ããããšãæãŸããããç¥ããª
ãã æã奜ãŸãã宿œäŸã«ãããŠãå åŽããŠãŒãïŒ
ïŒã¯ãã¢ã¯ãªã«ãããªã¢ã»ãã«ã»ã«ããŒã¹ãåã¯
é©åœãªç¡¬è³ªPVCã®ãããªå®è³ªçã«U.V.ãééã
ãææããäœããããã³ã¹ãããã³å©çšæ§äžŠã³ã«
U.V.ééæ§ã®é¢ããã¿ãŠã¢ã¯ãªã«ãæã奜ãŸã
ãææã§ãããåŸã€ãŠæåã®å®æœäŸã«ãããŠçæ³
çã«äœ¿çšãããã æŽã«ç¬¬ïŒããã³ïŒå³ãåç §ããŠãå€åŽããŠãŒã
ïŒïŒãå åŽããŠãŒãïŒïŒã«ã奜ãŸããã¯ã¹ããŒãµ
ïŒïŒã«ãã€ãŠå軞çã«ãšãã€ãããããã¹ããŒãµ
ïŒïŒãçšãããšãã€ãã¯ãå žåçã«ã¯å€åŽããŠãŒ
ãïŒïŒãã¹ããŒãµïŒïŒããã³å åŽããŠãŒãïŒïŒã
äžç·ã«ååŠçã«ã溶æ¥ãããã®ã«é©ããæº¶åªã䜿
çšããããšã«ãã€ãŠå¯å°ç¶æ ã«è¡ããããå€åŽã
ãŠãŒãïŒïŒäžã«ã¯ç §å°ããã¹ãæ¶²äœè©Šæãããã
ãåãåã€ããæŸåºãããããå ¥å£ããã³åºå£ïŒ
ïŒããšãã€ããããã奜ãŸãã宿œäŸã«ãããŠã¯
ãããã®å£ïŒïŒã¯ãªã¢ãŒåã³ãã¯ã¿ãŒã§ããã ã¹ããŒãµïŒïŒã¯çªãåºãâæâç¶ã®çªèµ·ããã€
ã®ãèªãããããããã¯å ¥å£ïŒïŒããã³åºå£ïŒïŒ
ã®å察åŽã®å£ã«äœçœ®ããã®ã奜ãŸããããã®ãã
ãªçªèµ·ã¯ãæµããªãâãã®å Žæã«èç©ããããšã«
ãªã€ãããç¥ããªãâæµéãéœåè¯ãæžãããã
ã®ãããªçªèµ·ã¯å®éã«ã¯ãããªã圢ããšã€ãŠãã
ãããšã¯æããã§ãããææãªãã°ãã¹ãŠãåé€
ããŠãããã 第ïŒå³ãæ¬çºæã®åå¥ã®å®æœäŸãæãããã®ã§
ãããããã§ã¯åäžã®å®€ããã«ãïŒïŒãšå軞æ¹å
ã®ããŠãŒãïŒïŒã«ãã€ãŠåœ¢æããããã®æ«ç«¯ïŒïŒ
ã¯ãšããã·ã®ãããªé©åœãªææã§å°ãããããã
ã®å Žåãå æºïŒïŒã®ã¬ã©ã¹ããã³ææïŒïŒã«å¯ç
çã«æ¥çããããšãã§ããç §å°ããã¹ã现èãå«
ã詊æãšã»ãšãã©çžäºäœçšããªãææãé©ããŠã
ããšããããããŠãŒãïŒïŒã«ã¯ãæ¶²äœææãåã
åã€ããæŸåºãããããå ¥å£ããã³åºå£ïŒïŒãå
ãã€ããããã宀å ã®æµãã®æ¹åã¯éèŠã§ãªãã
ã©ã¡ãã®æ¹åã«æµããŠããããããã第ïŒå³åã¯
第ïŒå³ã«ç€ºãåã®ã©ã¡ããã倿°çšãããããªå Ž
åã«ã¯ã第ïŒå³ã«ç€ºãããã«åçŽã«äžŠã¹ãããšã
奜ãŸãããæµãã¯åºããé éšãžé²ãããã«èšèšã
ãããïŒæ¬ã®è£ 眮ã䜿ãå Žåã§ãã€ãŠããããã¯
空æ°ã®æ³¡ãé€å»ããããã«å¥œãŸããæµãã®é 眮ã§
ãã€ãŠããããã®æ³¡ã¯ãé€å»ãããªãå¥ã®é 眮ã§
ã¯æç²ãããŠããŸãã 第ïŒå³ã¯ã«ã»ãããšããŠããã«åŒçšããæã奜
ãŸãã宿œäŸã§ãããã«ã»ããã¯è€æ°ã®ç §å°å®€ïŒ
ïŒããã¡ããã®åã ã¯ç¬¬ïŒå³ã«ç€ºãã宿œäŸãšã
æ§é äžã¯ã»ãåãã§ãããçæ³çãªé 眮ã¯ãã®ã
ããªç §å°å®€ïŒïŒãïŒåãã€ããå®éçæ§é çå¶çŽ
ããã³äœ¿ãæããèæ ®ããŠããã®ãããªå®€ããã
ããå€ããåã¯ããããå°ã䜿ã€ãŠããããç §å°
ç®¡ã®æ°ããµããè¡æ¶²ããã®åã ã®ç®¡ã匷å¶çã«æµ
ãããã«ãªããšããããæµããæ¶²ã«åœããç §å°é
ãå¢å ããããšã¯å®¹æã«çè§£ãããã 第ïŒå³ã«ç€ºãã«ã»ããã§ãè¡æ¶²ã¯å ¥å£ïŒïŒãé
ããŠç §å°å®€ïŒïŒã«é£çµ¡ãããå ¥å£ïŒïŒã¯ã«ã¢ãŒã
ãã¯ã§ããããæº¶åªæº¶æ¥ã®ãããªäœããã®é©åœãª
ææ®µã«ãã€ãŠããŠãŒãã³ã°ã»ãããä»çããŠãã
端ãªãå ¥å£ãã€ãã§ãããã©ã¡ããã§ãããç §å°
ããã¹ãæ¶²ã¯ããããäžè¬ã«ã¯äžæ¹ãžæµãããã
ããåºå£ïŒïŒã次ã®ç §å°å®€ã®å ¥å£ïŒïŒã«ã€ãªãã
ãã¬ãã·ãã«åã¯ãã¬ãã·ãã«ã§ãªãããŠãŒãç³»
ããæã亀åçµåææ®µïŒïŒã«ãã€ãŠäžæ¹ãžæµã
ãããã®ããã»ã¹ã¯ãç¢å°ã®æ¹åã«ãµãŒãã³ãã€
ã³æµïŒsurpentine flowïŒãçæãããããã¯ç©º
æ°æ³¡ã®ãããªãã®ãé€ãã®ã«ããæå¹ã§ããããš
ãããã€ããç §å°å®€ïŒïŒãééããæ¶²æµããæµã
ã®æ¹åã«ãããããã©ã³ãïŒïŒããã®ç §å°ã«ãã€
ãŠçãã圱é¿ãåãããªãã°éæ¹åãçšããŠãã
ãããšã¯æããã§ãããæåŸã«æ¶²ã¯æåŸã®ç §å°å®€
ïŒïŒã®åºå£ïŒïŒã«éããã«ã»ããåºå£ïŒïŒãéã€
ãŠã«ã»ããããæŸåºãããã第ïŒå³ã§ãã®åºå£
ã¯ãåºå£é£çµããŠãŒãïŒïŒãçµãŠãã«ã»ããå ¥å£
ïŒïŒãšåãåŽã«ç€ºãããããã®é åã¯é£çµããã³
æäœã容æã«ããããšããã®ã¯ãã¹ãŠãã®ãããª
é£çµã¯ã«ã»ããã®çæ¹ã®ç«¯ã§è¡ãããããã§ã
ãã奿³ãšããŠãã«ã»ããåºå£ïŒïŒãã«ã»ããå ¥
å£ïŒïŒãšåã圢åŒã§ãçŽæ¥ãæåŸã®åºå£ïŒïŒã«ã
ã€ãŠããããåç §å°å®€ïŒïŒãç §å°å®€å ã«äœçœ®ãã
ç §å°ã©ã³ãïŒïŒãæ¯ããã¿ãïŒïŒããã€ãã¿ãå·»
ã®éå£ã¯å å£ïŒïŒãšçµã¿åã€ãŠã©ã³ãïŒïŒãåã
å·»ã空æ°ã¹ããŒã¹ã圢æããããããã¯å€§æ°ãšèª
ç±ã«é£çµ¡ããŠã第ïŒå³ã®ããŠãŒãïŒïŒã«ãã€ãŠåœ¢
æãããå éšå·åŽå®€ãšåæ§ã®æ¹æ³ã§å·åŽããã 第ïŒå³ã«ã¯åã ã«äº€åããé£çµããŠãŒãææ®µïŒ
ïŒã瀺ãããŠãããšã¯ãããé©åœãªæåããã»ã¹
ãçšããŠãã®ãããªææ®µãã«ã»ããèªèº«ã®åºæã®
éšåã«ãªãããã«ããŠãããããšã¯åœç¶ã§ããã
ãã®ãããªé åã¯ãé£çµéšãå°ãããŠãäžéœåãª
æŒãã®ãããæ©äŒãæžãããªããã°ãªããªããšã
ã芳ç¹ããã¯å¥œéœåã§ããããã³ãïŒïŒããããŠ
ãŒãã»ããïŒå³ç€ºãããŠããªãïŒãçµç±ãããã
ãªã³åã¯ãã®ä»ã®ååºé»æ¢æº¶æ¶²ã®æµããããã³é
å¿åé¢åšïŒïŒãããã³ãïŒïŒãéãè¡æ¶²ã®æµã
ã¯ãã³ã³ãããŒã«ããã«ïŒïŒã«ãã€ãŠé çªã«ã³ã³
ãããŒã«ãããã¯ã©ã³ãïŒïŒïŒ¡ïŒïŒ¢ããã³ïŒ£ã«ã
ã€ãŠã³ã³ãããŒã«ããããé å¿åé¢åšïŒïŒã¯ãæ
äœè ãããŒãïŒïŒããèŠãŠãå šè¡ã®å¯çœè¡çéšå
ãçæããæã決å®ãããé£ç¶ãããŒã¿ã€ãã§ã
ãããã¹ãŠã®æº¶æ¶²ã¯ãããã«ïŒïŒã«æ¥ããå åŽã«
ã€ãäžãã€ãŠããããã°ïŒå³ç€ºãããŠããªãïŒã«
éãããããåŠçåŸãåŠçè¡æ¶²ãšæªåŠçè¡æ¶²ã¯ã
ãªããã¹ã¿ã³ãïŒïŒã«ã€ãäžããããæ£è ã«æ»ã
ããã å®éšäŸ ïŒ äž¡ç«¯ãâãªã³ã°ãšãšããã·ææãšã®çµã¿åã
ãã§å°ããã第ïŒå³ã«ç€ºããããªè£ 眮ããã·ã«ã
ãã¢F8T5ïŒBLBã©ã³ããšå ±ã«çšãããç°¡åãªå
埪ç°ã·ã¹ãã ããè¡æ¶²ãå ¥ããåçŽã«çœ®ãããè£
眮ã®åºéšãšé£çµ¡ãããã¬ãã·ãã«ããã°ãå«ãã§
æãããã«äœããããè¡æ¶²ã¯ã©ã³ãã®åšå²ãæµ
ãã宀ãäžæ¹ã«æµããåºå£ãªãªãã€ã¹ããåºãŠã
ããã°ã«æ»ããããçµåã¯ãããŒã©ãŒãã¢ãªã³ã°
ã¿ã€ããã³ããéãæãããã¬ãã·ãã«ããŠãŒã
ïŒã¿ã€ãŽã³ããŠãŒãã³ã°ïŒTygon tubingïŒã«ãã€
ãŠè¡ããããå路容éã¯ãïŒã¡ããã·ããœã©ã¬ã³
62nïœïŒmlãå«ãåžéæ°é®®ããè¡æ¶²150mlã§ãã€
ããèµ€è¡çæ¿åºŠã¯6.7Ã106ïŒmlããããŠçœè¡çæ¿
床ã¯1.4Ã106ïŒmlã§ãã€ããè£ çœ®ã®ãã©ã€ãã³ã°
容éã¯25mlã§è¡æ¶²å±€ã®åãã¯0.070ã€ã³ãïŒçŽ
0.178cmïŒãå³ã¡ãã«ããšãåšå²ãžã€ã±ããåã¯ã
ãŠãŒãã®å é¢ãšã®è·é¢ã0.07ã€ã³ãïŒçŽ0.178cmïŒ
ã§ãã€ããè¡æµé床ã¯ïŒåé50mlã«ç¶æãããã
ååŠç詊æããU.V.被æã®åã«æ¡åããããã
ããäžè©Šæããäžã«äžè£ 眮ããã€äžè¿°ã®ãããªå
è·¯ãééããããã®è³æã6.3ãžãŠãŒã«ïŒmlã§ç §
å°ãããå šãåãã·ã¹ãã ã§ãïŒã·ãªãŒãºã«ïŒæ¬
ã®ããŠãŒãã䜿ãããŠããç¹ã ããç°ãªãã·ã¹ã
ã ãäœã€ããåããŠãŒããééããæµãã¯åºéšã
ããŠã€ãºããžãšæµããïŒåéã«190ãžãŠãŒã«ã®ç §
å°ãè¡ããããçœè¡çã¯ïŒæ¥éã¯ç掻åããã€ã
ãšãèªããããããã®ç掻åã¯ãåœæ¥è ã«ã¯åšç¥
ã®æ¹æ³ã§ããããªãã¶ã³ãã«ãŒã®è²çŽ ã«ããåŠç
ãšæ€é¡æ€æ»ã«ããæ±ºå®ããããåŸãããçµæãäž
ã«ïŒè¡šã«ç€ºãã
ã衚ã
å®éšäŸ ïŒ
第ïŒå³ã«ç€ºãããã®ãšåæ§ã®è£
眮ïŒã±ãåçŽã«
é åããäžç³»åã«ãªãããã«é£çµããã
Fenwall350c.c.鿬ããã¯ïŒãã®å ¥å£ã¯è¡æ¶²ãã³
ãã«çªãéã€ãŠããïŒã®åºå£ã第äžã®è£ 眮ã®å ¥å£
ã«çµåãããã è¡æ¶²ãã³ãã¯ã50mlïŒminã®æµããç¶æããã
å æºã¯ã·ã«ããã¢F8T5ïŒBLBã©ã³ãã§ãããã©
ã³ãããšãå·»ããŠãå€åŽçŽåŸ7/8â³ïŒçŽ2.22cmïŒã®
U.V.ééæ§å åŽããŠãŒããããããã¹ãåè·¯ã«
20åéçé žå¡©ç·©è¡é£å¡©æ°ŽïŒPBSïŒãæµã蟌ã¿ã
ããããæé€ããã第ïŒå³ã«ç€ºãè£ çœ®ãïŒã±å«ã
æ» èå路系ã«ããªãŠãŒã³ããªã¬ã¹åŠç
ïŒleukophorescedïŒã®ïŒæéåã«ïŒâã¡ããã·ã
ãœã©ã¬ã³ãçµå£çã«æåããæ£è ããã®ããªãŠãŒ
ã³ããªã¬ã¹åŠçãããè¡æ¶²175c.c.ãæµã蟌ãã ã
ãã®è¡æ¶²è©Šæã®çŽ°èæ¿åºŠã¯ã2.8Ã108èµ€è¡çïŒml
ããã³3.8Ã106çœè¡çïŒmlã§ãã€ãããã®è¡æ¶²ã
20åéãã©ã³ããã€ããã«ã50mlïŒminã®é床ã§
ã·ã¹ãã ã埪ç°ããããååŠçãã詊æããšã€ã
ïŒT0ïŒãã©ã³ããã€ããïŒæé25åè¡æ¶²ã埪ç°ã
ãã詊æT1ããšã€ãããã®åŸéæ¬ããã¯ãåè·¯
ããé€å»ããéèç³»ãšåèç³»ãã€ãªããè¡æ¶²æº¶æ¶²
ãæŽã«ïŒæé20å埪ç°ããããã®æç¹ã§è©ŠæT2
ãåŸãã 现èïŒåãããã®æå¹è¡šé¢ç©ã¯163cm2ãæå¹é·
ã23.5cmã现èïŒåãããã®ãã©ã€ãã³ã°å®¹é28
mlãè¡æ¶²å±€ã®åãçŽ1.6mmã现èïŒåãããã®å¹³
åãã¯ãŒ5.5ããªã¯ããïŒcm2ãšèšç®ãããã詊æ
T1ã¯çްèã94ãžãŠãŒã«ïŒmlã§ç §å°ãããããšã
瀺ããT2ã¯190ãžãŠãŒã«ïŒmlã§ç §å°ãããããšã
瀺ãã 现èã®ç掻åã¯ïŒæ¥ç®ããïŒæ¥ç®ãŸã§èªããã
ãã现èã¯ã墿®å¹å°å¯Ÿçްèã®æ¯ãïŒïŒïŒã«ãªã
ããã«å¢æ®å¹å°ãå ããããšã«ãã€ãŠäœå€ã§ä¿æ
ãããã墿®å¹å°ã¯ããŠã·èä»è¡æž 30ïŒ ããã³70
ïŒ RPMIãå«ã¿åšç¥ã®çµç¹å¹é€å¹å°ã§ããã åŸãããçµæã以äžã®ïŒè¡šã«ç€ºãã
é åããäžç³»åã«ãªãããã«é£çµããã
Fenwall350c.c.鿬ããã¯ïŒãã®å ¥å£ã¯è¡æ¶²ãã³
ãã«çªãéã€ãŠããïŒã®åºå£ã第äžã®è£ 眮ã®å ¥å£
ã«çµåãããã è¡æ¶²ãã³ãã¯ã50mlïŒminã®æµããç¶æããã
å æºã¯ã·ã«ããã¢F8T5ïŒBLBã©ã³ãã§ãããã©
ã³ãããšãå·»ããŠãå€åŽçŽåŸ7/8â³ïŒçŽ2.22cmïŒã®
U.V.ééæ§å åŽããŠãŒããããããã¹ãåè·¯ã«
20åéçé žå¡©ç·©è¡é£å¡©æ°ŽïŒPBSïŒãæµã蟌ã¿ã
ããããæé€ããã第ïŒå³ã«ç€ºãè£ çœ®ãïŒã±å«ã
æ» èå路系ã«ããªãŠãŒã³ããªã¬ã¹åŠç
ïŒleukophorescedïŒã®ïŒæéåã«ïŒâã¡ããã·ã
ãœã©ã¬ã³ãçµå£çã«æåããæ£è ããã®ããªãŠãŒ
ã³ããªã¬ã¹åŠçãããè¡æ¶²175c.c.ãæµã蟌ãã ã
ãã®è¡æ¶²è©Šæã®çŽ°èæ¿åºŠã¯ã2.8Ã108èµ€è¡çïŒml
ããã³3.8Ã106çœè¡çïŒmlã§ãã€ãããã®è¡æ¶²ã
20åéãã©ã³ããã€ããã«ã50mlïŒminã®é床ã§
ã·ã¹ãã ã埪ç°ããããååŠçãã詊æããšã€ã
ïŒT0ïŒãã©ã³ããã€ããïŒæé25åè¡æ¶²ã埪ç°ã
ãã詊æT1ããšã€ãããã®åŸéæ¬ããã¯ãåè·¯
ããé€å»ããéèç³»ãšåèç³»ãã€ãªããè¡æ¶²æº¶æ¶²
ãæŽã«ïŒæé20å埪ç°ããããã®æç¹ã§è©ŠæT2
ãåŸãã 现èïŒåãããã®æå¹è¡šé¢ç©ã¯163cm2ãæå¹é·
ã23.5cmã现èïŒåãããã®ãã©ã€ãã³ã°å®¹é28
mlãè¡æ¶²å±€ã®åãçŽ1.6mmã现èïŒåãããã®å¹³
åãã¯ãŒ5.5ããªã¯ããïŒcm2ãšèšç®ãããã詊æ
T1ã¯çްèã94ãžãŠãŒã«ïŒmlã§ç §å°ãããããšã
瀺ããT2ã¯190ãžãŠãŒã«ïŒmlã§ç §å°ãããããšã
瀺ãã 现èã®ç掻åã¯ïŒæ¥ç®ããïŒæ¥ç®ãŸã§èªããã
ãã现èã¯ã墿®å¹å°å¯Ÿçްèã®æ¯ãïŒïŒïŒã«ãªã
ããã«å¢æ®å¹å°ãå ããããšã«ãã€ãŠäœå€ã§ä¿æ
ãããã墿®å¹å°ã¯ããŠã·èä»è¡æž 30ïŒ ããã³70
ïŒ RPMIãå«ã¿åšç¥ã®çµç¹å¹é€å¹å°ã§ããã åŸãããçµæã以äžã®ïŒè¡šã«ç€ºãã
ã衚ã
å¹³åå€ã§ããïŒ
æ¶²äœè©Šæãå«ã宀ã®åãããããéã詊æã®æµ
éãã©ã³ãã®ãã¯ãŒåºåããã³çŽ°èæ¿åºŠã¯ãèŠæ±
ããã广ãåŸãããã«æ¶²äœè©Šæã«ææã®ãšãã«
ã®ãŒãåœãŠãããã«ã奜éœåã«èšèšããŠããããš
ã¯ãåœæ¥è ã«ã¯æçœã§ãããåŸã€ãŠæ¬çºæã¯ãã
ãããã¿ã€ãã®å æºã®äœ¿çšã«ãèæ ®ããã宿œäŸ
ã«çšããåºãU.V.ã¹ãã¯ãã«åž¯ã«éããããã®
ã§ãªãã
æ¶²äœè©Šæãå«ã宀ã®åãããããéã詊æã®æµ
éãã©ã³ãã®ãã¯ãŒåºåããã³çŽ°èæ¿åºŠã¯ãèŠæ±
ããã广ãåŸãããã«æ¶²äœè©Šæã«ææã®ãšãã«
ã®ãŒãåœãŠãããã«ã奜éœåã«èšèšããŠããããš
ã¯ãåœæ¥è ã«ã¯æçœã§ãããåŸã€ãŠæ¬çºæã¯ãã
ãããã¿ã€ãã®å æºã®äœ¿çšã«ãèæ ®ããã宿œäŸ
ã«çšããåºãU.V.ã¹ãã¯ãã«åž¯ã«éããããã®
ã§ãªãã
第ïŒå³ã¯å¥œãŸãã宿œäŸãå³ã§ããããæèŠå³
ã§ããã第ïŒå³ã¯ç¬¬ïŒå³ã®åè§£æèŠå³ã§ããã第
ïŒå³ã¯åäžã®å®€ããã€å¥ã®å®æœäŸã®æèŠå³ã§ã
ãã第ïŒå³ã¯ã«ã»ããã®æã奜ãŸãã宿œäŸã®æ
èŠå³ã§ããã第ïŒå³ã¯ç¬¬ïŒå³ã®è£ 眮ãçšããåšå ·
ã瀺ãæèŠå³ã§ããã ïŒïŒâŠâŠå æºãïŒïŒâŠâŠå åŽããŠãŒããïŒïŒâŠ
âŠå€åŽããŠãŒããïŒïŒâŠâŠã¹ããŒãµãïŒïŒâŠâŠã¹
ããŒãµãªã³ã°ãïŒïŒâŠâŠæ«ç«¯ãïŒïŒâŠâŠç §å°å®€ã
ïŒïŒâŠâŠå ¥å£ãïŒïŒâŠâŠäº€åçµåææ®µãïŒïŒâŠâŠ
åºå£ãïŒïŒâŠâŠå ¥å£ãïŒïŒâŠâŠã©ã³ããïŒïŒâŠâŠ
å å£ãïŒïŒâŠâŠåºå£ãïŒïŒïŒïŒïŒâŠâŠãã³ããïŒ
ïŒâŠâŠé å¿å颿©ãïŒïŒâŠâŠããŒããïŒïŒâŠâŠã
ãªããã¹ã¿ã³ããïŒïŒâŠâŠããã«ãïŒïŒâŠâŠã³ã³
ãããŒã«ããã«ã
ã§ããã第ïŒå³ã¯ç¬¬ïŒå³ã®åè§£æèŠå³ã§ããã第
ïŒå³ã¯åäžã®å®€ããã€å¥ã®å®æœäŸã®æèŠå³ã§ã
ãã第ïŒå³ã¯ã«ã»ããã®æã奜ãŸãã宿œäŸã®æ
èŠå³ã§ããã第ïŒå³ã¯ç¬¬ïŒå³ã®è£ 眮ãçšããåšå ·
ã瀺ãæèŠå³ã§ããã ïŒïŒâŠâŠå æºãïŒïŒâŠâŠå åŽããŠãŒããïŒïŒâŠ
âŠå€åŽããŠãŒããïŒïŒâŠâŠã¹ããŒãµãïŒïŒâŠâŠã¹
ããŒãµãªã³ã°ãïŒïŒâŠâŠæ«ç«¯ãïŒïŒâŠâŠç §å°å®€ã
ïŒïŒâŠâŠå ¥å£ãïŒïŒâŠâŠäº€åçµåææ®µãïŒïŒâŠâŠ
åºå£ãïŒïŒâŠâŠå ¥å£ãïŒïŒâŠâŠã©ã³ããïŒïŒâŠâŠ
å å£ãïŒïŒâŠâŠåºå£ãïŒïŒïŒïŒïŒâŠâŠãã³ããïŒ
ïŒâŠâŠé å¿å颿©ãïŒïŒâŠâŠããŒããïŒïŒâŠâŠã
ãªããã¹ã¿ã³ããïŒïŒâŠâŠããã«ãïŒïŒâŠâŠã³ã³
ãããŒã«ããã«ã
Claims (1)
- ãç¹èš±è«æ±ã®ç¯å²ã ïŒ äººäœããæ¡åãããæ¶²äœãç §å°ããããã®è£
眮ã§ãã€ãŠã (a) 第äžã®çŽåŸãæããïŒåãããã¯ãã以äžã®
现é·ãç §å°å æºãšã (b) åèšç¬¬äžã®çŽåŸãã倧ãã第äºã®çŽåŸãæã
ãŠåèšå现é·ãç §å°å æºã®åšå²ã«å軞çã«é 眮
ããããã€ãã®äž¡ç«¯ã¯åèšç §å°å æºãšå¯å°ç¶æ
ã«ãã¿åããããïŒåãããã¯ãã以äžã®ç¬¬äž
ã®ããŠãŒãã§ãã€ãŠããã®ç¬¬äžã®ããŠãŒãã®å
åŽè¡šé¢ãšåèšç §å°å æºã®å€åŽè¡šé¢ãšã®éã«åœ¢æ
ããã第äžã®å®€ãšé£çµ¡ããå ¥å£ããã³åºå£ææ®µ
ãå«ã第äžã®ããŠãŒããå ·åããè£ çœ®ã ïŒ åèšç¬¬äºã®çŽåŸãã倧ãã第äžã®çŽåŸãæ
ããåèšåç §å°å æºããã³ç¬¬äžã®ããŠãŒããšå軞
çã«é 眮ãããïŒåãããã¯ãã以äžã®ç¬¬äºã®ã
ãŠãŒããšããã®ç¬¬äºã®ããŠãŒãã®ç«¯ãåèšç¬¬äžã®
ããŠãŒãã®å€åŽè¡šé¢ãšãšãã«å¯å°ããŠç¬¬äžã®ããŠ
ãŒãã®å€åŽè¡šé¢ãšç¬¬äºã®ããŠãŒãã®å åŽè¡šé¢ãšã®
éã«ç¬¬äºã®å®€ã圢æããææ®µãšãããã«å«ã¿ã第
äºã®ããŠãŒãã¯ç¬¬äºã®å®€ãšé£çµ¡ããå ¥å£ããã³åº
å£ææ®µãæããŠãæ¶²äœã¯åèšç¬¬äžãŸãã¯ç¬¬äºã®ã©
ã¡ããã®å®€ãééããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®è£ 眮ã ïŒ åèšè£ 眮ã¯ãåèšç¬¬äžã®å®€å士ãé£çµ¡ããæ¥
ç¶ææ®µãããã«åããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒ
ã®è£ 眮ã ïŒ åèšæ¶²äœã¯ç¬¬äžããã³ç¬¬äºã®äž¡æ¹ã®å®€ãéé
ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé èšèŒã®è£ 眮ã ïŒ åèšç¬¬äžã®å®€ã¯å€§æ°ãšé£çµ¡ããç¹èš±è«æ±ã®ç¯
å²ç¬¬ïŒé èšèŒã®è£ 眮ã ïŒ åèšç §å°å æºã¯å¯èŠãèµ€å€ãUVCïŒçæ³¢é·çŽ«
å€ç·ïŒãUVBïŒäžæ³¢é·çŽ«å€ç·ïŒããã³UVAïŒé·æ³¢
é·çŽ«å€ç·ïŒã®åã¹ãã¯ãã«æŸå°å æºãããªã矀ã
ãéžæãããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ãªãã第ïŒé
ã®ããããäžé èšèŒã®è£ 眮ã ïŒ åèšç §å°å æºã¯ã·ã«ããã¢F8T5ïŒBLBã©ã³
ãã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ãªãã第ïŒé ã®ã
ãããäžé èšèŒã®è£ 眮ã ïŒ åèšç¬¬äžã®ããŠãŒãã¯å®è³ªçã«çŽ«å€ç·
ïŒUVïŒééæ§ã§ããç¹èš±è«æ±ã®ç¯å²ç¬¬ïŒé ãªã
ã第ïŒé ã®ããããäžé èšèŒã®è£ 眮ã
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53723183A | 1983-09-29 | 1983-09-29 | |
| US537231 | 1983-09-29 | ||
| US65060284A | 1984-09-17 | 1984-09-17 | |
| US650602 | 1984-09-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS60142862A JPS60142862A (ja) | 1985-07-29 |
| JPH0547222B2 true JPH0547222B2 (ja) | 1993-07-16 |
Family
ID=27065421
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP59202133A Granted JPS60142862A (ja) | 1983-09-29 | 1984-09-28 | 现èãç §å°åŠçããããã®è£ 眮 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0138489B1 (ja) |
| JP (1) | JPS60142862A (ja) |
| AU (1) | AU566710B2 (ja) |
| CA (1) | CA1253115A (ja) |
| DE (1) | DE3468172D1 (ja) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4708715A (en) * | 1984-10-29 | 1987-11-24 | Mcneilab, Inc. | Light array assembly for photoactivation patient treatment system |
| US4681568A (en) | 1984-10-29 | 1987-07-21 | Mcneilab, Inc. | Valve apparatus for photoactivation patient treatment system |
| DE3650139T2 (de) * | 1985-07-05 | 1995-03-09 | Hutchinson Fred Cancer Res | Verfahren zum reduzieren der immunogenizitÀt und zum induzieren immunologischer toleranz. |
| JPS62284656A (ja) * | 1986-06-03 | 1987-12-10 | æ ªåŒäŒç€Ÿã€ãŒãŒã« | è¡æ¶²ã®æ®ºèæ¹æ³ |
| GB8630102D0 (en) * | 1986-12-17 | 1987-01-28 | Gunn A | Blood processing device |
| AU2616788A (en) * | 1987-11-06 | 1989-06-01 | Francis William Arnold | Device for use in the treatment of lymphocytes |
| GB8807380D0 (en) * | 1988-03-29 | 1988-05-05 | Gunn A | Blood processing apparatus |
| MY108087A (en) * | 1989-07-12 | 1996-08-15 | Randy L Stinson | Apparatus and method for irradiating cells. |
| US5150705A (en) * | 1989-07-12 | 1992-09-29 | Stinson Randy L | Apparatus and method for irradiating cells |
| DE69131797T2 (de) * | 1990-12-20 | 2000-06-29 | Baxter International Inc., Deerfield | Systeme und verfahren zum gleichzeitigen entfernen von freien und gebundenen verunreinigungen aus flÃŒssigkeiten, wie blut, mit hilfe einer photoaktiven therapie sowie zellseparationstechniken |
| CA2074806A1 (en) * | 1990-12-20 | 1992-06-21 | Ludwig Wolf Jr. | Systems for eradicating contaminants in fluids |
| ZA919934B (en) * | 1990-12-20 | 1992-09-30 | Baxter Int | Systems and methods for eradicating contaminants using photoactive materials in fluids like blood using discrete sources of radiation |
| JP3051997B2 (ja) * | 1990-12-20 | 2000-06-12 | ãã¯ã¹ã¿ãŒãã€ã³ã¿ãŒãã·ã§ãã«ãã€ã³ã³ãŒãã¬ã€ããã | æ¶²äœäžã®æ±æç©ãæ ¹çµ¶ããã·ã¹ãã åã³æ¹æ³ |
| US5527704A (en) | 1994-12-06 | 1996-06-18 | Baxter International Inc. | Apparatus and method for inactivating viral contaminants in body fluids |
| RU2144385C1 (ru) * | 1997-05-13 | 2000-01-20 | ÐÑÑÑПвÑкОй ÐлаЎОÑлав ÐазОЌОÑÐŸÐ²ÐžÑ | СпПÑПб пПвÑÑÐµÐœÐžÑ ÐžÐŒÐŒÑММÑÑ ÑвПйÑÑв пеÑелОваеЌПй аÑÑПкÑПвО |
| US6596275B1 (en) | 1998-03-30 | 2003-07-22 | I.D.M. Immuno-Designed Molecules | Monocyte derived cells with immunosuppressive properties, process for their preparation and their uses in pharmaceutical compositions |
| US6219584B1 (en) * | 1999-07-09 | 2001-04-17 | Therakos, Inc. | Method and system for determining an effective amount of light energy to delivery to fluids having targets for the light energy |
| NL1015999C2 (nl) * | 2000-08-23 | 2002-02-26 | A J Van Liebergen Holding B V | Inrichting voor het verwarmen van bloed of andere fysiologische vloeistoffen. |
| RU2192893C2 (ru) * | 2000-11-21 | 2002-11-20 | ÐаÑÑМÑй ÑеМÑÑ ÑеÑЎеÑМП-ÑПÑÑЎОÑÑПй Ñ ÐžÑÑÑгОО ОЌ. Ð.Ð. ÐакÑлева Ð ÐÐÐ | СпПÑПб кПÑÑекÑОО МаÑÑÑеМОй лОпОЎМПгП ÑПÑÑава Ð¿Ð»Ð°Ð·ÐŒÑ |
| DE102010044805B4 (de) * | 2010-09-09 | 2017-03-23 | Heraeus Noblelight Gmbh | Reaktor zur Entkeimung oder Aufbereitung einer FlÃŒssigkeit mittels UVC-Strahlung |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2074909A (en) * | 1936-11-16 | 1937-03-23 | Maximilian L Herzig | Activation device for the heliopyretic treatment of matter |
| FR2020234A1 (ja) * | 1968-10-09 | 1970-07-10 | Atomenergi Ab | |
| FR2426473A1 (fr) * | 1978-05-26 | 1979-12-21 | Carraz Gilbert | Procede et dispositif de traitement de la leucemie par circulation extra-corporelle du sang |
| US4321919A (en) * | 1979-12-11 | 1982-03-30 | Leukocyte Research, Inc. | Method and system for externally treating human blood |
-
1984
- 1984-09-27 CA CA000464189A patent/CA1253115A/en not_active Expired
- 1984-09-28 DE DE8484306667T patent/DE3468172D1/de not_active Expired
- 1984-09-28 AU AU33714/84A patent/AU566710B2/en not_active Expired
- 1984-09-28 JP JP59202133A patent/JPS60142862A/ja active Granted
- 1984-09-28 EP EP84306667A patent/EP0138489B1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| EP0138489B1 (en) | 1987-12-23 |
| DE3468172D1 (en) | 1988-02-04 |
| EP0138489A1 (en) | 1985-04-24 |
| CA1253115A (en) | 1989-04-25 |
| JPS60142862A (ja) | 1985-07-29 |
| AU3371484A (en) | 1985-04-18 |
| AU566710B2 (en) | 1987-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH0547222B2 (ja) | ||
| EP0368902B1 (en) | Method for eradicating infectious contaminants in tissues | |
| US10058646B2 (en) | Blood bag system and process for the inactivation of pathogens in platelet concentrates by use of the blood bag system | |
| US10583192B2 (en) | Anaerobic blood storage and pathogen inactivation method | |
| DE60124095T2 (de) | Verfahren zur inaktivierung von mikroorganismen unter verwendung von photosensibilisatoren | |
| US12207651B2 (en) | Apparatus and methods for irradiating organ perfusates | |
| US5628727A (en) | Extracorporeal virioncidal apparatus | |
| JPH05505128A (ja) | æ¶²äœäžã®æ±æç©ãæ ¹çµ¶ããã·ã¹ãã åã³æ¹æ³ | |
| JPH09500015A (ja) | è¡æ¶²ã®ãŠã£ã«ã¹äžæŽ»æ§åã®ããã®ã·ã¹ãã | |
| CN110639038A (zh) | å©çšæ žé»çŽ å ååŠæ³çæŽ»è¡æ¶²æåç åäœç讟å€åæ¹æ³ | |
| US20210290834A1 (en) | Polychromatic Phototherapy Device and Method | |
| US12329149B2 (en) | Apparatus and methods for irradiating organ perfusates | |
| US20260033486A1 (en) | Method for Sustaining and Evaluating Isolated Organs | |
| PL227190B1 (pl) | Urzadzenie do fotobiomodulacji krwi podczas krazenia pozaustrojowego | |
| HK40025031A (en) | Apparatus and methods for irradiating organ perfusates | |
| UA5464U (uk) | ÐÑОÑÑÑÑй ÐŽÐ»Ñ ÐµÐºÑÑÑакПÑпПÑалÑМПгП ÑлÑÑÑаÑÑПлеÑПвПгП ПпÑПЌÑÐœÐµÐœÐœÑ ÑÑаМÑÑÑзÑÐ¹ÐœÐžÑ ÑÑЎОМ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |